started · updated
Neuralink announces Blindsight device to restore vision
Elon Musk has announced that Neuralink, his neuroengineering startup, has completed the engineering phase for its second commercial product, Blindsight. The device is designed to restore vision to individuals who are blind due to physical trauma, degenerative diseases, or those who were born without sight.
Unlike the company’s first product, Telepathy, which decodes motor intentions to allow paralyzed patients to control digital interfaces, Blindsight acts as a sensory input neuroprosthesis. The system uses external high-precision cameras to capture images, which are then converted into electrical pulses. These pulses are delivered via ultra-thin microfilaments implanted in the primary visual cortex, bypassing damaged eyes or optic nerves to create visual perception directly in the brain.
While the device has received FDA breakthrough device designation, it currently awaits regulatory approval to begin human clinical trials. The company has not yet provided specific timelines or human trial data.
Entities
Elon Musk · Food and Drug Administration · Meta · Neuralink · NeuroXess